Financial Disclosure Statement

MSACL 2018 US Abstract Title:
Mass Spectrometric Studies of Apolipoprotein Proteoforms and their Role in Lipid Metabolism and Type 2 Diabetes
Dobrin Nedelkov
Isoformix

DescriptionY/NSource
Grantsno
Salaryno
Board Memberno
Stockyes Isoformix
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no